ulcers. Post-treatment, first-void urine sample of the patient was negative for Ureaplasma spp. both by culture and PCR. The patient was counseled for safe sex practices and advised for regular follow-ups at a interval of 2 weeks.
Risk of retroviral transmission is increased in the presence of co-infections with organisms such as HSV, syphilis, chancroids and genital mycoplasmas. [4] To the best of our knowledge, this is the first report of co-infection with U. parvum and HSV in HIV-infected individual.
Because of the frequency with which ureaplasmas occur in healthy asymptomatic individuals, it has been suggested that only certain subgroups of the species are pathogenic. The majority of human Ureaplasma isolates belong to U. parvum (biovar 1). Ureaplasma urealyticum (biovar 2) is isolated less often. [3] Ureaplasma consists of 14 serovars. Among the different serovars of U. parvum, serovar 3/14 is the most frequent serovar detected and suggests a possible pathogenic role of U. parvum serovar 3/14. [3] Our patient was also infected with U. parvum serovar 3/14, thereby supporting its pathogenic potential.
Our patient had a CD4 + count of 88/µl. Previous studies have shown an association of HSV with CD4 + counts, but no such definitive association with genital mycoplasmas is known. [4] Hence, screening of all HIV patients for genital mycoplasmas, irrespective of their CD4 + counts should be done. This case highlights the importance of screening of all patients with high risk behavior, for multiple co-pathogens infecting the genital tract. Early detection and treatment of sexually transmitted pathogens in HIV-infected patients would prove prudent to control retroviral transmission.
Screening, treatment, and follow-up of syphilis patients: Issues, concerns and efforts to improve current paradigms
Sir, Despite an effective treatment being available since the penicillin introduction, syphilis remains an important concern worldwide, also for the limitations encountered with the available serological tests for diagnosis and follow-up.
Recently, confidence in benzathine penicillin G(BPG) for treatment of early syphilis (ES) wavered based on the literature concerning its serological treatment failures and on the remarkable number of patients (immunocompetent and HIV-infected) with late complications despite adequate BPG therapy. [1] Our aim is to renew the discussion of current paradigms for syphilis diagnosis, treatment, and follow-up.
For syphilis screening, we simultaneously used treponemal test (TT) and non-TTs (NTTs).
Letters to Editor
Regarding therapy, in the last 5 years, we treated 32 patients with early and late syphilis with an enhanced regimen that adds doxycycline (100 mg/twice daily for 20 days) and ceftriaxone (1 g/daily for 10 days intramuscularly) to conventional BPG. Dosages and treatment duration have been decided based on the use of these antibiotics in other spirochetal infections with cerebrospinal fluid (CSF) involvement. [2] All patients are still in follow-up but to date no side effects, relapses or complications have been reported, and both NTT and TT titers decreased over four-fold within 6 months.
To diagnose syphilis, the Center for Disease Control and Prevention (CDC) guidelines recommend a NTT, rapid plasma reagin or venereal disease research laboratory (VDRL), and to confirm the diagnosis, to test positive sera with a TT, Treponema pallidum particle agglutination assay or immunoenzymatic assay (EIA). To initiate the screening algorithm with a TT is not recommended for the high rate of false positive results with these tests. [3] HIV patients have an even higher rate of serological failure, and viable T. pallidum have been isolated from their CSF following standard treatment. [1] A possible explanation for BPG treatment failure could be attributed to its inability to reach specific body districts that can be invaded by T. pallidum, attaining in the CSF only 1-2% of the serum concentration and not achieving treponemicidal levels in the central nervous system (CNS), eye and inner ear. Furthermore, CSF penetration is hampered by the lack of meningeal inflammation in the earlier syphilis stage when neuroinvasion occurs. [1] BPG phenotypic resistance in vivo cannot be excluded: Giacani et al. recently found that during primary experimental syphilis, transcription of two T. pallidum sigma factors significantly increases as infection progresses towards the pathogen immune clearance, suggesting that these transcriptional regulators may help T. pallidum to respond to harmful stimuli in the host environment. Given the ability of sigma factors to control numerous genes and cellular functions, the phenotypic changes induced in T. pallidum may also involve its impaired ability to proliferate, making it refractory to the BPG action. [4] Another hypothesis is that following antibiotic treatment and host immune attack; replicating spirochetes may descend to a state called "L-forms," that do not have cell walls and consequently, are not affected by antibiotics. These forms might revert to normal replicating bacteria in the absence of antibiotics. [5] The question is: Could other treatment regimens be able to decrease late complications?
We implemented, therefore, a regimen that adds doxycycline and ceftriaxone to BPG.
Doxycycline is the most used tetracycline in CNS infections, as neuroborrelliosis, because it is lipophilic, readily absorbed after oral administration and enters the eye and CSF more effectively than other tetracyclines. Doxycycline elimination half-life is long (15-25 h) and median CSF concentration in patients treated orally with 200 mg/daily is 0.6 µg/ml, 4 h after administration. [2] Ceftriaxone has a half-life in serum (7-8 h) long enough to allow once-daily administration and a CSF penetration higher than BPG. A 1 g daily dose achieves CNS levels well above the minimal inhibitory concentration for T. pallidum (0.0006 μg/ml). [2] All our patients that received the enhanced treatment are still in follow-up but to date no side-effects, relapses or complications have been reported. In all of them, both NTT and TT titers decreased over fourfold within 6 months. However, we emphasize that the decrease of serological titers and the resolution of cutaneous lesions may be insufficient to predict a therapeutic success since cutaneous lesions may resolve, and antibody titers may decline even without therapy. We are aware that a larger cohort of patients and an appropriately controlled trial with long-term follow-up are required to evaluate the efficacy of this treatment, but our encouraging results prompted us to bring this therapy to the attention of other sexually transmitted diseases centres.
Since Doxycycline is contraindicated in pregnant and lactating women and children younger than 8 years, we currently follow CDC guidelines for these categories.
For syphilis follow-up, CDC recommends a quantitative NTT for monitoring the serological response to treatment. TT titers do not correlate with disease activity and can remain positive for life, regardless of treatment. Therefore, they are considered unreliable for the follow-up. However, NTT titres might become nonreactive over time even without therapy. We think that TT should be added in the follow-up, especially in late latent syphilis, where NTT are often negative.
In fact, in our experience, among 7 late latent syphilis patients, only 1 had a positive VDRL test, and TT titers always decreased after therapy.
In conclusion, we emphasize that for syphilis diagnosis the clinical history and the physical examination should be considered together with serology. Along with the laboratory results, the clinical follow-up is mandatory to exclude progression towards late complications after therapy. Finally, we should not resign ourselves to accept suboptimal results in syphilis treatment and look forward to defining an optimal treatment for a disease that is still a great concern for healthcare providers.
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Awareness of sexually transmitted infection (STI)/reproductive tract infections (RTI)
and HIV/AIDS in STI/RTI -affected married women of rural areas of Varanasi district, Uttar Pradesh: A cross-sectional study Sir, Awareness of sexually transmitted infections (STIs)/reproductive tract infections (RTIs) and their modes of transmission, methods of protection help in the prevention of STIs/RTIs and HIV infection. In a study on school going adolescence girls, it was found that only 42% of
